Heron Patrick J's Form 4 filing
Imago BioSciences, Inc. (IMGO) · filed Jul 20, 2021
- Accession no.
- 0001567619-21-013730
- Filed
- Jul 20, 2021, 5:54 PM ET
- Trade date
- Jul 20, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 6 derivative transactions. Open-market purchases total $3.00M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Heron Patrick JCIK 0001365617 | Director |
| Frazier Healthcare VII, L.P.CIK 0001553071 | 10% Owner |
| Frazier Healthcare VII-A, L.P.CIK 0001575192 | 10% Owner |
| FHM VII, L.L.C.CIK 0001654631 | 10% Owner |
| FHM VII, L.P.CIK 0001654632 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | Common Stock | PPurchaseAcquired | +41,582 | $16.00 | +$665,312 | 41,582 | Indirect | |
| Jul 20, 2021 | Common Stock | PPurchaseAcquired | +145,918 | $16.00 | +$2,334,688 | 145,918 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionAcquired | +341,932 | –F3 | – | 383,514 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionAcquired | +211,069 | –F3 | – | 594,583 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionAcquired | +64,360 | –F3 | – | 658,943 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionAcquired | +1,199,890 | –F3 | – | 1,345,808 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionAcquired | +740,673 | –F3 | – | 2,086,481 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionAcquired | +225,850 | –F3 | – | 2,312,331 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | Common Stock | CConversionDisposed | −341,932 | $0.00 | $0 | 0 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionDisposed | −211,069 | $0.00 | $0 | 0 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionDisposed | −64,360 | $0.00 | $0 | 0 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionDisposed | −1,199,890 | $0.00 | $0 | 0 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionDisposed | −740,673 | $0.00 | $0 | 0 | Indirect | |
| Jul 20, 2021 | Common Stock | CConversionDisposed | −225,850 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Each share of the Issuer's Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering on July 20, 2021 and had no expiration date.
Referenced by the price of 6 transactions in Table I.